Polyether Ether Ketone (PEEK) Interbody Devices Market Report 2025

The polyether ether ketone (PEEK) interbody devices market size has grown strongly in recent years. It will grow from $1.79 billion in 2024 to $1.92 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period can be attributed to the rising adoption in non-medical industries, growth in medical tourism, increased demand for MRI-compatible implants, improvement in favorable clinical outcomes, and a rise in chronic back pain cases.

The polyether ether ketone (PEEK) interbody devices market size is expected to see strong growth in the next few years. It will grow to $2.56 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth expected in the forecast period can be attributed to the increase in spinal disorders, expanding vehicle production, growth in the automotive industry, rising healthcare expenditure, and greater use of hybrid material devices. Key trends during this period include technological advancements, progress in medical technology, adoption of advanced spinal implants, the innovative potential of PEEK technology, and the development of advanced surgical techniques.

The rising prevalence of spinal disorders is anticipated to drive growth in the PEEK interbody devices market. Spinal disorders encompass medical conditions affecting the spine, including bones, discs, nerves, and muscles. These disorders are increasing due to sedentary lifestyles, as prolonged sitting and reduced physical activity weaken the muscles supporting the spine and increase spinal strain. PEEK interbody devices assist in treating spinal disorders by providing strong yet flexible support between vertebrae, enhancing spinal stability, and encouraging natural bone growth while maintaining clear imaging during follow-up scans. For example, in May 2023, Spinal Cord Inc., a US-based resource for people affected by spinal cord injuries and their families, reported approximately 18,000 new cases of spinal cord injuries in the United States during 2023, with an estimated 302,000 people living with spinal cord injuries nationwide. Thus, the increasing prevalence of spinal disorders is fueling the growth of the PEEK interbody devices market.

Leading companies in the PEEK interbody devices market are developing innovative products such as porous cervical interbody fusion (IBF) systems to improve osseointegration, enhance implant stability, and promote faster patient recovery. A porous cervical IBF system is a medical implant used in spinal surgeries, specifically for cervical spine fusion, designed to replace damaged or degenerated cervical intervertebral discs and encourage bone growth between adjacent vertebrae, ultimately stabilizing the spine. For instance, in August 2022, Innovasis, a US-based medical device firm, received 510(k) clearance from the US Food and Drug Administration for HAcancellous PEEK-C, the first hydroxyapatite (HA) porous PEEK interbody fusion device intended for cervical spine procedures. The device is designed for single-level anterior cervical discectomy and fusion (ACDF) surgeries between C2 and T1 in skeletally mature patients diagnosed with degenerative disc disease. It features a porous structure combined with hydroxyapatite to support bone growth and accelerate fusion. This product aims to improve spinal fusion outcomes by promoting better bone integration and faster fusion.

In February 2025, Medtronic, an Ireland-based medical technology company, acquired nano surface technology assets from Nanovis for an undisclosed sum. This acquisition enables Medtronic to strengthen its interbody fusion systems by incorporating Nanovis’ advanced surface treatment technologies. Nanovis is a US-based manufacturer of PEEK interbody fusion devices.

Major players in the polyether ether ketone (peek) interbody devices market are Medtronic Inc., Stryker Corporation, Zimmer Biomet Holdings Inc., Globus Medical Inc., NuVasive Inc., Orthofix Medical Inc., Exactech Inc., Xtant Medical Holdings Inc., Alphatec Spine Inc., Spinal Elements Inc., Providence Medical Technology Inc., FossiLabs LLC, Life Spine Inc., Curiteva Inc., Medacta International S.A., LDR Holding Corporation, Cavendish Implants Limited, SINTX Technologies Inc., In2Bones Global Inc., Xilloc Medical International B.V.

North America was the largest region in the polyether ether ketone (PEEK) interbody devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polyether ether ketone (PEEK) interbody devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the polyether ether ketone (PEEK) interbody devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polyether ether ketone (PEEK) interbody devices market consists of sales of cervical anterior interbody fusion (CAIF) devices, transpedicular lumbar fusion devices and lateral lumbar interbody fusion (LLIF) devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The PEEK interbody devices market research report is one of a series of new reports that provides PEEK interbody devices market statistics, including PEEK interbody devices industry global market size, regional shares, competitors with a PEEK interbody devices market share, detailed PEEK interbody devices market segments, market trends and opportunities, and any further data you may need to thrive in the PEEK interbody devices industry. This PEEK interbody devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Polyether ether ketone (PEEK) interbody devices are medical implants made from polyether ether ketone (PEEK), a high-performance polymer commonly used in spinal fusion surgeries. These devices are placed between vertebrae to provide support and stability after the removal of damaged or degenerated disc material. PEEK is preferred for its biocompatibility, radiolucency, and mechanical properties that closely resemble those of human bone.

The main types of PEEK interbody devices include posterolateral fusion devices, interbody fusion devices, anterior lumbar interbody fusion devices (ALIF), extreme lateral interbody fusion devices (XLIF), posterior lumbar interbody fusion devices (PLIF), transforaminal lumbar interbody fusion devices (TLIF), and others. Posterolateral fusion devices are spinal implants used in surgeries to fuse vertebrae from the posterior (back) and lateral (side) approaches. These devices are applied in spinal fusion surgery, degenerative disc disease, spinal trauma, and spinal deformity. Distribution channels include direct sales, online sales, and third-party distributors. They are used by various end-users such as hospitals and clinics, ambulatory surgery centers, and others.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.